Glaukos Corp’s Stock Is Sell After Today’s Huge Decline

Share with your friends


The stock of Glaukos Corp (NYSE:GKOS) is a huge mover today! The stock decreased 6.76% or $1.61 on December 11, hitting $22.21. About 71,601 shares traded hands. Glaukos Corp (NYSE:GKOS) has risen 6.00% since November 12, 2015 and is uptrending. It has outperformed by 10.42% the S&P500.
The move comes after 5 months negative chart setup for the $762.08M company. It was reported on Dec, 12 by We have $20.43 PT which if reached, will make NYSE:GKOS worth $60.97 million less.

According to Zacks Investment Research, “Glaukos Corporation is an ophthalmic medical technology company. The Company develops, manufactures and markets medical devices for the treatment of glaucoma. Its product pipeline consists of iStent Inject, the iStent Supra and iDose. The company operates primarily in United States, Germany, Europe, the Asia Pacific, Canada and internationally. Glaukos Corporation is headquartered in Laguna Hills, California.” Get a free copy of the Zacks research report on Glaukos Corp (GKOS).

Glaukos Corp - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Add Comment